These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6128769)

  • 1. Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.
    Hyttel J
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):277-95. PubMed ID: 6128769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J
    Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
    Arnt J; Hyttel J; Larsen JJ
    Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):363-72. PubMed ID: 6152104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.
    Hyttel J; Overø KF; Arnt J
    Psychopharmacology (Berl); 1984; 83(1):20-7. PubMed ID: 6429698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of citalopram (Lu 10-171) on tranylcypromine and tryptophan-induced wet-dog shakes in rats.
    Keshavan HJ; Gurbani NK; Dandiya PC
    Psychopharmacology (Berl); 1980; 70(2):209-12. PubMed ID: 6159662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a specific 5HT uptake inhibitor (citalopram) on drug accumulation by rat lung slices.
    Drew R; Siddik ZH
    Pharmacology; 1980; 20(1):27-31. PubMed ID: 6929555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin uptake inhibitors and the prejunctional effects of serotonin on peripheral sympathetic nerves.
    Adler-Graschinsky E; Butta NV; Elgoyhen AB
    Life Sci; 1986 Jul; 39(1):61-8. PubMed ID: 3487690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
    Arnt J; Overø KF; Hyttel J; Olsen R
    Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants and serotonin neurons of the raphe.
    Constantinidis J; Dick P; Tissot R
    Neuropsychobiology; 1981; 7(3):113-21. PubMed ID: 6785659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
    Pawłowski L; Nowak G
    J Pharm Pharmacol; 1987 Dec; 39(12):1003-9. PubMed ID: 2894425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT-uptake inhibition potentiates antinociception induced by morphine, pethidine, methadone and ketobemidone in rats.
    Larsen JJ; Hyttel J
    Acta Pharmacol Toxicol (Copenh); 1985 Sep; 57(3):214-8. PubMed ID: 2865865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1983; 35(1):49-57. PubMed ID: 6604264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
    Pawlowski L; Nowak G; Górka Z; Mazela H
    Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNS effects of citalopram, a new serotonin inhibitor antidepressant (a quantitative pharmaco-electroencephalography study).
    Itil TM; Menon GN; Bozak MM; Itil KZ
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):397-409. PubMed ID: 6592676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal 5-HT or NA uptake inhibition potentiates supraspinal morphine antinociception in rats.
    Larsen JJ; Arnt J
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):72-5. PubMed ID: 6583982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant.
    Gastpar M; Gastpar G
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):319-25. PubMed ID: 6959196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.
    Hyttel J; Larsen JJ
    J Neurochem; 1985 May; 44(5):1615-22. PubMed ID: 2580950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.